The Prevalence of the Classical and Non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 1, 2013-02 ,pp. : 104-111

Bentham Science Publishers

Access to resources Recommend Favorite

HPLC and MS Analysis for the Identification and Characterisation of Peptides Presented in the Context of the Non-Classical Human Leukocytes Antigen (HLA) Class I Molecule HLA-E

By  

Current Pharmaceutical Design, Vol. 15, Iss. 28, 2009-10 ,pp. : 3325-3335

Bentham Science Publishers

Access to resources Recommend Favorite

Prolyl Oligopeptidase Structure and Dynamics

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 3, 2011-05 ,pp. : 306-310

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Classical Drug Metabolism Enzymes: The Curious Case of Phenylalanine 4-Monooxygenase

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 6, 2006-08 ,pp. : 405-412

Bentham Science Publishers

Access to resources Recommend Favorite

Dynamic mechanisms of non-classical antagonism by competitive AT 1 receptor antagonists

By Lew M.J.   Ziogas J.   Christopoulos A.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 10, 2000-10 ,pp. : 376-381

Elsevier

Access to resources Recommend Favorite